Babikian Healthcare Products Added to Import Alert 66-40: The CGMP Pattern Behind the Detention and What Every Quality Director Managing Dietary Supplement and OTC Drug Sites Must Know
FDA added Babikian Healthcare Products to Import Alert 66-40 with a blanket Detention Without Physical Examination across its entire drug product line — with no companion Warning Letter publicly available to explain the underlying finding.